PHEXXI

This brand name is authorized in United States

Active ingredients

The drug PHEXXI contains a combination of these active pharmaceutical ingredients (APIs):

1 Lactic acid
UNII F9S9FFU82N - LACTIC ACID, L-
Read about Lactic acid
2 Citric acid
UNII 2968PHW8QP - CITRIC ACID MONOHYDRATE

Potassium citrate is indicated for the management of renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis of any etiology, uric acid lithiasis with or without calcium stones. When potassium citrate is given orally, the metabolism of absorbed citrate produces an alkaline load. The induced alkaline load in turn increases urinary pH and raises urinary citrate by augmenting citrate clearance without measurably altering ultrafilterable serum citrate. Thus, potassium citrate therapy appears to increase urinary citrate principally by modifying the renal handling of citrate, rather than by increasing the filtered load of citrate.

Read about Citric acid
3 Potassium
UNII NPT6P8P3UU - POTASSIUM BITARTRATE
Read about Potassium

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 69751-100

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.